212 related articles for article (PubMed ID: 7172502)
41. In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases.
Mantovani A
Int J Cancer; 1981 Feb; 27(2):221-8. PubMed ID: 7287217
[TBL] [Abstract][Full Text] [Related]
42. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
43. Effects of inactivated streptococci (OK-432) on macrophage functions in mice.
Colotta F; Bersani L; Polentarutti N; Peri G; Mantovani A
J Immunopharmacol; 1985; 7(4):437-49. PubMed ID: 3866797
[TBL] [Abstract][Full Text] [Related]
44. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
45. Cytokine stimulation of antibody-dependent cellular cytotoxicity (ADCC) enhances cytolytic but not binding capacity of peritoneal macrophages.
Fehr HG; Fan S; Lötzerich H; Appell HJ
Anticancer Res; 1990; 10(3):821-5. PubMed ID: 2114820
[TBL] [Abstract][Full Text] [Related]
46. Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice.
Mantovani A; Luini W; Candiani GP; Spreafico F
Int J Immunopharmacol; 1980; 2(4):333-9. PubMed ID: 7009446
[TBL] [Abstract][Full Text] [Related]
47. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
48. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
[TBL] [Abstract][Full Text] [Related]
49. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
Ruco LP; Meltzer MS
J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
[No Abstract] [Full Text] [Related]
50. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages.
Keller R; Keist R; Frei K
Eur J Immunol; 1990 Mar; 20(3):695-8. PubMed ID: 2108046
[TBL] [Abstract][Full Text] [Related]
51. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
52. The nature of the effector cell in antibody-dependent, cell-mediated cytolysis (ADCC): the cytotoxic activity of murine tumor cells and peritoneal macrophages.
Handwerger BS; Koren HS
Clin Immunol Immunopathol; 1976 Mar; 5(2):272-81. PubMed ID: 1277588
[No Abstract] [Full Text] [Related]
53. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
54. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
55. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
56. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
57. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
58. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.
Mantovani A; Peri G; Polentarutti N; Bolis G; Mangioni C; Spreafico F
Int J Cancer; 1979 Feb; 23(2):157-64. PubMed ID: 761940
[TBL] [Abstract][Full Text] [Related]
59. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).
Männel DN; Moore RN; Mergenhagen SE
Infect Immun; 1980 Nov; 30(2):523-30. PubMed ID: 7002801
[TBL] [Abstract][Full Text] [Related]
60. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
